Endoscopic variceal ligation plus beta‐blockers (EVL+ BB) is currently recommended for
variceal rebleeding prophylaxis, a recommendation that extends to all patients with cirrhosis …

The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

It is estimated that globally there are approximately 100 million persons with serological
evidence of current or past HCV infection, and that HCV causes about 700 000 deaths each …

No all‐oral, direct‐acting antiviral regimens have been approved for children with chronic
hepatitis C virus (HCV) infection. We conducted a phase 2, multicenter, open‐label study to …

Summary Background Hepatitis C virus (HCV) prevalence estimates for adults and high-risk
groups have been widely published, but the disease burden in children is poorly …

Cystic fibrosis (CF)‐associated liver disease (CFLD) is a hepatobiliary complication of CF.
Current diagnostic modalities rely on nonspecific assessments, whereas liver biopsy is the …

Background & Aims Chronic hepatitis C virus (HCV) infection is a global health burden.
Although HCV infection rarely contributes to morbidity during childhood, most HCV-infected …

Currently, there are no interferon‐free treatments available for hepatitis C virus (HCV)–
infected patients younger than 12 years. We evaluated the safety and effectiveness of the all …

The worldwide prevalence of hepatitis C virus (HCV) infection in children is 0.05%-0.4% in
developed countries and 2%-5% in resource-limited settings, where inadequately tested …

Children with chronic hepatitis C virus infection have limited treatment options. We
evaluated the all‐oral combination of sofosbuvir and ribavirin in adolescents aged 12‐17 …